Development of simple vaccine using vitamin D3 adjuvant

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    RIKEN
  • Principal Investigator

    Unspecified Hidehiro Fukuyama
  • Research Location

    Japan
  • Lead Research Institution

    Laboratory for Lymphocyte Differentiation, Center for Integrative Medical Sciences
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Our goal is to establish a safe and simple vaccine for COVID-19. Herd immunity requires the global community to be immunized simultaneously. We will work to develop a needle-less vaccine system by taking an advantage of our new adjuvant discovered at RIKEN.